Han IC, Critser DB, Amram AL, et al. - This research was sought to present the retention of large, tubular, non-dissolving foreign bodies because of a complication of the intravitreal dexamethasone implant (Ozurdex). Researchers conducted a single-center, retrospective chart review of patients who were found to have retained, non-dissolvable tubular foreign bodies in the vitreous cavity for more than 6 months (the expected dissolution time of the implants) after Ozurdex injections. They examined ocular symptomatology and multimodal imaging. The results considered that the persistent, non-dissolving, tubular foreign bodies can be seen in the vitreous cavity for years after injection of the Ozurdex implant. The findings recognized that clinicians should be aware of this complication that has the potential to cause visual symptoms and ocular morbidity.